Company: SRPT
Filing Date: 2025-08-29
Form Type: 8-K
Source: 0001193125-25-192794
Chunk: 3

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-08-29
Form: 8-K
Item: Item 1.01
Chunk 3
---
.1      Indenture, dated as of August 28, 2025, by and between Sarepta Therapeutics, Inc. and U. S. Bank Trust Company, National Association (including the form of the 4.875% Convertible Senior Note du...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      4.2      Form of 4.875% Convertible Senior Note due 2030 (included in Exhibit 4.1).                                                                                                                            
      104      The cover page from this Current Report on Form 8-K, formatted in Inline XBRL